Why Do Varicose Veins Hurt? The Mechanisms Behind Venous Pain, From Pressure to Inflammation

People with varicose veins or chronic venous insufficiency (CVI) tend to describe the same things: aching, a heavy or dragging feeling, throbbing, burning, cramps at night. What is much less often explained is why — by what route a vein that no longer works properly ends up producing a pain signal.

This article sets out the main theories and mechanisms in order. It goes past "poor circulation hurts" to the cellular and molecular level, because the details are what make the everyday clinical patterns — worse in the evening, better with the legs up, better in compression — make sense.

1. Venous hypertension: where it starts

The root cause of venous pain is venous hypertension. In a healthy venous system, one-way valves stop blood falling back down between steps, so each stride pushes blood efficiently toward the heart. When the valves fail, or the vein wall itself weakens, blood refluxes and pressure inside the leg veins stays abnormally high.

In a healthy person, ankle venous pressure falls to roughly 20–30 mmHg after walking. In someone with significant valve incompetence it stays above 40 mmHg — ambulatory venous hypertension. That persistent, abnormal pressure is the starting point for every pathological change that follows (Eberhardt & Raffetto, Circulation 2014; Raffetto & Khalil, Vessel Plus 2021).

2. Mechanism 1: mechanical stretch of the vein wall

The vein wall and the tissue around it contain free nerve endings and mechanoreceptors — nociceptors of the Aδ (fast, sharp) and C-fibre (slow, dull) types.

As pressure rises, the vein distends abnormally, and the nociceptors in the adventitia and surrounding connective tissue are stimulated directly. A dilated vein can also physically compress nearby nerve fibres. This is the usual explanation for the heaviness and pressure people feel after standing for a long time.

A simple clinical observation supports it: raise the leg above the heart and the pressure drops, and the symptoms ease quickly. Pain that responds this fast to a change in pressure is not coming from fixed structural damage — it is coming from a pressure-driven mechanical stimulus.

3. Mechanism 2: endothelial injury and glycocalyx disruption

Raised pressure and abnormal flow — reflux, turbulence — damage the glycocalyx, the glycoprotein layer that coats the endothelial cells lining the vein. The glycocalyx protects the endothelium and senses shear stress.

Once that layer is disrupted, the endothelium malfunctions almost immediately. Junctional proteins between cells weaken and permeability rises; expression of adhesion molecules (ICAM-1, VCAM-1, E-selectin) climbs sharply. White blood cells begin sticking to the endothelium and migrating out into the tissue — leukocyte trapping (Diaz, Gianesini & Khalil, Int Angiol 2024; Silverberg et al., Dermatol Ther 2023).

4. Mechanism 3: leukocyte trapping and tissue inflammation

Under sustained venous hypertension, leukocyte trapping recurs in the microcirculation — capillaries and post-capillary venules. Trapped neutrophils, monocytes and macrophages become activated and release inflammatory mediators.

Those with a direct role in pain include:

Prostaglandin E2 (PGE2) — lowers the threshold of nociceptors so that stimuli which would normally be painless now register: peripheral sensitisation.

Bradykinin — a vasodilator and a potent direct stimulator of nociceptors in tissue.

TNF-α, IL-1β, IL-6 — cytokines that sustain chronic inflammation and prolong the sensitised state.

Reactive oxygen and nitrogen species (ROS/RNS) — oxidative stress that damages cells and stimulates pain fibres (Raffetto et al., J Clin Med 2020; Raffetto & Khalil, Vessel Plus 2021).

This is not a one-off reaction. As long as the venous hypertension persists, leukocyte trapping and mediator release repeat, and a vicious cycle sets in.

5. Mechanism 4: matrix metalloproteinases and remodelling

Trapped leukocytes and activated endothelium over-express matrix metalloproteinases (MMPs), which break down the collagen and elastin of the extracellular matrix and structurally weaken the vein wall.

A weaker wall dilates further, the valves work even less well, pressure rises further — a chain reaction. The breakdown products of the matrix themselves may act as signalling molecules that disturb the tissue environment and stimulate nociceptors.

Hypoxia-inducible factor (HIF) rises in the locally hypoxic environment created by venous stasis and drives MMP expression further, forming a positive feedback loop (Raffetto & Khalil, Vessel Plus 2021; Diaz et al., Int Angiol 2024).

6. Mechanism 5: tissue oedema and nerve compression

Sustained venous hypertension raises capillary pressure, and by Starling's forces fluid moves out into the interstitium. The increased endothelial permeability described above accelerates this.

The resulting tissue oedema produces pain by two routes. Physically, the swollen tissue compresses nerve fibres and nociceptors. Chemically, the metabolites that accumulate in the fluid — lactate, potassium, inflammatory mediators, protein breakdown products — stimulate nociceptors directly.

This is why the legs swell and ache more as the day goes on, and why lying down or elevating them helps: gravity worsens venous hypertension while standing, and elevation relieves it.

7. Mechanism 6: chronic inflammation of the skin — the link to stasis dermatitis

If venous hypertension persists for years, the inflammation extends to the skin. Stasis dermatitis (venous eczema) is its characteristic expression.

With adhesion molecules such as ICAM-1 and VCAM-1 upregulated, activated leukocytes infiltrate the dermis; macrophage-derived cytokines are implicated in the itch. MMP-driven matrix degradation together with TGF-β1 drives fibrosis, progressing to lipodermatosclerosis — and at that stage pain is present even at rest (Silverberg et al., Dermatol Ther 2023).

8. The character of the pain reflects the mechanism

Each of these mechanisms shows up in the pattern of symptoms patients describe.

Worse in the evening, better in the morning. A day of ambulatory venous hypertension accumulates oedema and inflammatory mediators, peaking in the evening. Overnight, lying flat, venous pressure normalises and the morning is easier.

Worse in heat. Heat dilates veins, increasing their capacity and making return harder. Summer and hot baths make symptoms worse for this reason.

Better in compression stockings. External compression narrows the vein and assists the valves, reducing venous hypertension directly — which is, indirectly, evidence that venous hypertension is the core driver of the pain.

Relief after treatment. Closing the refluxing vein — by laser, radiofrequency, or adhesive — removes the venous hypertension at its source, and the inflammatory cascade downstream of it stops. The improvement in leg pain that patients report within days to weeks of treatment is the strongest clinical support for this whole model.

9. The integrated model

Put together, the chain runs:

Valve failure or vein wall weakness → reflux → ambulatory venous hypertension → vein wall distension (mechanical nociceptor stimulation) → glycocalyx injury → endothelial dysfunction → adhesion molecule upregulation → leukocyte trapping and migration → release of inflammatory mediators (PGE2, bradykinin, TNF-α, IL-1β, ROS) → peripheral nociceptor sensitisation → MMP over-expression → matrix degradation and further wall weakening → capillary permeability → tissue oedema → nerve compression and metabolite accumulation → pain signalling → with time, skin changes (stasis dermatitis, pigmentation, lipodermatosclerosis) → persistent pain

Unless the venous hypertension is relieved, this cycle amplifies itself.

In closing

Venous pain is not "tiredness" or vaguely "poor circulation." It is a defined, self-reinforcing sequence that begins with venous hypertension and runs through glycocalyx injury, endothelial dysfunction, leukocyte-mediated inflammation, MMP over-expression and tissue oedema.

Understanding the mechanism also explains why compression, venoactive drugs and vein procedures relieve pain — and why leaving the condition untreated can progress to skin changes and ulceration. Heavy, aching legs are worth a proper vascular assessment rather than being written off as fatigue.

---

References

• Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):333-346. (PMID: 25047584)
• Raffetto JD, Khalil RA. Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins. Vessel Plus. 2021;5:36. (PMID: 34250453)
• Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment. J Clin Med. 2020;10(1):29. (PMID: 33374372)
• Diaz JA, Gianesini S, Khalil RA. Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease. Int Angiol. 2024;43(6):563-590. (PMID: 39873224)
• Silverberg J, Jackson JM, Kirsner RS, et al. Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension. Dermatol Ther (Heidelb). 2023;13(4):935-950. (PMID: 36949275)
• Meissner MH, Gloviczki P, Bergan J, et al. Primary chronic venous disorders. J Vasc Surg. 2007;46 Suppl S:54S-67S. (PMID: 18068562)